Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05028855
Other study ID # CASCAS
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 14, 2017
Est. completion date August 30, 2026

Study information

Verified date February 2024
Source The First Hospital of Jilin University
Contact Yi Yang, MD, PhD
Phone 0086-13756661217
Email doctor_yangyi@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

In this multi-center prospective observational study within a cohort of symptomatic cerebral atherosclerotic stenosis (sCAS) patients, 850 subjects were planed to be enrolled to explore the relationship between cerebral autoregulation (CA) and stroke recurrence, determine the threshold values of CA parameter for predicting stroke recurrence associated with particular stenosis.


Description:

Ischemic stroke is a tremendous public health burden that seriously endangers the health of Chinese population symptomatic cerebral atherosclerotic stenosis (sCAS) is responsible for about 33-50% of ischemic stroke in China and highly associated with the risk of stroke recurrence. Cerebral autoregulation (CA) is the main protective mechanism that modulates cerebral blood flow to satisfy regional cerebral perfusion demands despite of variations in arterial blood pressure (ABP). Thus, CA supposed to be particularly considered when choosing individual therapeutic strategy in sCAS patients. In clinical practice, applying transcranial Doppler combined with servo-controlled plethysmograph assessing CA has been proved a feasible method in cerebral atherosclerotic stenosis patients. Especially in those severe stenosis patients, CA is probably compromised in varying degrees, whereas whether and to what extent CA parameters have the capability to predict stroke recurrence has not been illustrated. Thus, the aim of the study was to assess CA after acute ischemic stroke or transient ischemic attack within 2 years follow-up to explore the relationship between CA and stroke recurrence and determine the threshold values of CA parameter to predict stroke recurrence. CA measurement will be performed at 0-3 and 10-30 days after ischemic cerebrovascular events. Clinical information, neuroimaging data, biochemical examinations and follow-up information will be collected and recorded in case report form (CRF) once signing of informed consent.


Recruitment information / eligibility

Status Recruiting
Enrollment 850
Est. completion date August 30, 2026
Est. primary completion date December 24, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age ranging from 18 to 80, both genders - Unilateral internal carotid artery (ICA) or M1 segment of middle cerebral artery (MCA) stenosis (rate of stenosis ranging from 50-99%) - Acute ischemic cerebrovascular events (TIA or ischemic stroke) within cerebral stenotic artery supplying area - Onset of disease <30 d before enrollment - Modified Ranking Scale (mRS) =1 before stroke onset - National Institutes of Health Stroke Scale (NIHSS) =20 - Sufficient bilateral temporal bone windows for insonation of the middle cerebral artery - Be conscious, and able to cooperate with CA assessment - Willing to participate and sign the informed consent Exclusion Criteria: - Vertebral artery (VA), basilar artery (BA), anterior cerebral artery (ACA), or posterior cerebral artery (PCA) stenosis; Bilateral internal carotid artery (ICA) or M1 segment of middle cerebral artery (MCA) stenosis(rate of stenosis ranging from 50-99%) - Patients who have received or plan to undergo intravascular interventional treatment/endarterectomy - Other intracranial diseases, including cerebral hemorrhage (primary or secondary), intracranial neoplasm, aneurysm, arteriovenous malformation, etc. - Evidence for embolic stroke, such as atrial fibrillation, prosthetic valve surgery, and suspected endocarditis, etc. - Arrhythmia, anemia and hyperthyroidism which may influence the stability of cerebral blood flow diagnosed by two physicians by electrocardiogram and laboratory tests. - Dementia, severe anxiety, depression, and other mental diseases - Malignant neoplasm and expected lifetime <2 years - Enrolled in other clinical trails within 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Cerebral autoregulation assessment
Cerebral autoregulation assessment will be conducted by specialized neurovascular ultrasound doctors during 0-3 and 10-30 days after stroke onset.The recorded data will be stored for further cerebral autoregulation analysis.

Locations

Country Name City State
China the First Hospital of Jilin University Changchun Jilin

Sponsors (10)

Lead Sponsor Collaborator
Yi Yang Eighth Affiliated Hospital, Sun Yat-sen University, Qilu Hospital of Shandong University, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shenzhen Second People's Hospital, The Affiliated Hospital of Qingdao University, The Affiliated Hospital of Yanbian University, The First Affiliated Hospital of Hebei North University, The First Affiliated Hospital of University of South China, The First Affiliated Hospital with Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stroke recurrence rate Ischemic cerebrovascular recurrence (TIA or ischemic stroke) within cerebral stenotic artery supplying area diagnosed by symptoms and imaging examinations. two years
Secondary The index of cerebral autoregulation Phase difference, gain and coherence of symptomatic cerebral atherosclerotic stenosis patients within 30 days ischemic cerebrovascular events onset. within 30 days ischemic cerebrovascular events onset
Secondary ischemic cerebrovascular recurrence rate All ischemic cerebrovascular recurrence (TIA or ischemic stroke) within two years follow-up diagnosed by symptoms and imaging examinations. two years
Secondary The first onset time of composite endpoint events within 2 years The composite endpoint events include fatal and nonfatal stroke (ischemic or hemorrhagic stroke), fatal and nonfatal myocardial infarction, transient ischemic attack (TIA) diagnosed by symptoms and imaging examinations. two years follow-up
Secondary mRS and Barthel score The changes of mRS and Barthel score within 2 years two years
Secondary The first onset time of each individual part of composite endpoint events within 2 years The first onset time of each individual part of composite endpoint events within 2 years two years follow-up
Secondary the NIHSS score The changes of NIHSS score from admission to discharge within 1 month
See also
  Status Clinical Trial Phase
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02478177 - Addressing Real-world Anticoagulant Management Issues in Stroke
Not yet recruiting NCT04378946 - Error Augmentation Motor Learning Training Approach in Stroke Patients N/A
Completed NCT00609115 - Sub-Acute Stroke Rehabilitation With AMES N/A
Completed NCT04103034 - A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers Phase 1
Completed NCT02207023 - Healthy Lifestyles After Stroke - Stroke Coach N/A
Completed NCT03417349 - Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke
Recruiting NCT02587949 - The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.
Completed NCT02735148 - The Effects of Body Weight Supported Treadmill Training On Balance In Stroke Patients N/A
Completed NCT02759627 - Does Isolated Robotic-Assisted Gait Training Improve Functional Status, Daily Living And Quality Of Life In Stroke? N/A
Terminated NCT02465034 - Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke N/A
Completed NCT01133106 - Living Well With Stroke N/A
Completed NCT00061022 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Completed NCT02725944 - Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and TIA
Not yet recruiting NCT04870684 - Thromboelastometry and Ischemic Stroke (ThromboPredict)
Terminated NCT03094715 - Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window N/A
Recruiting NCT05013762 - Fast Arm Motor Skill Training N/A
Not yet recruiting NCT01205490 - Changes in Cerebral Blood Flow With Spinal Manipulative Therapy vs. Voluntary Motion N/A
Recruiting NCT01144650 - Dapsone for Acute Ischemia Stroke Study Phase 2/Phase 3
Completed NCT00608582 - Transcranial Magnetic Stimulation to Improve Speech in Aphasia Phase 2